Arthrex Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Arthrex Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7531
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company that designs and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and wrist, foot and ankle, and hip related surgical products, orthobiologics and imaging and resection systems. It also provides medical education; surgical skills training programs; physician observation program; Surgical outcomes system (SOS) orthopaedic and sports medicine global registry; and patient education. The company markets its products directly and also through a network of distributors in the Americas, Europe, the Middle East, Africa, and Asia. Arthrex is headquartered in Naples, Florida, the US.

Arthrex Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Arthrex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Arthrex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Arthrex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Arthrex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Arthrex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Arthrex Inc, Medical Equipment, Deal Details 10
Partnerships 10
CellRight Technologies Enters into Distribution Agreement with Arthrex 10
CollPlant Enters into Distribution Agreement with Arthrex 11
Vivex Biomedical Partners with Arthrex 12
Novadaq Technologies Enters into Co-Marketing Agreement with Arthrex 13
Vomaris Enters into Distribution Agreement with Arthrex for Procellera Technology 14
Osiris Therapeutics Enters into Co-Development Agreement with Arthrex for Cartiform 15
Nuo Therapeutics Amends Licensing Agreement with Arthrex 16
Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System 17
Arthrex Inc – Key Competitors 18
Arthrex Inc – Key Employees 19
Arthrex Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Strategy And Business Planning 22
Nov 09, 2017: Arthrex Announces Plans for Expansion of Global Headquarters 22
Oct 16, 2017: Arthrex Announces Plans for New Surgical Device Manufacturing Facility 23
Corporate Communications 24
Mar 03, 2018: Arthrex Announces New Vice President of Strategic Development 24
Mar 14, 2017: Arthrex Welcomes Mark Ferguson, MD, as Director of Medical Education, Asia-Pacific (APAC) Region 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Arthrex Inc, Medical Equipment, Key Facts 2
Arthrex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Arthrex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Arthrex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Arthrex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Arthrex Inc, Deals By Market, 2012 to YTD 2018 8
Arthrex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CellRight Technologies Enters into Distribution Agreement with Arthrex 10
CollPlant Enters into Distribution Agreement with Arthrex 11
Vivex Biomedical Partners with Arthrex 12
Novadaq Technologies Enters into Co-Marketing Agreement with Arthrex 13
Vomaris Enters into Distribution Agreement with Arthrex for Procellera Technology 14
Osiris Therapeutics Enters into Co-Development Agreement with Arthrex for Cartiform 15
Nuo Therapeutics Amends Licensing Agreement with Arthrex 16
Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System 17
Arthrex Inc, Key Competitors 18
Arthrex Inc, Key Employees 19
Arthrex Inc, Subsidiaries 20

List of Figures
Arthrex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Arthrex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Arthrex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Arthrex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Arthrex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Arthrex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Arthrex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Arthrex Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Arthrex Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Groupe PSA:企業の戦略・SWOT・財務情報
    Groupe PSA - Strategy, SWOT and Corporate Finance Report Summary Groupe PSA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kezar Life Sciences Inc (KZR):製薬・医療:M&Aディール及び事業提携情報
    Summary Kezar Life Sciences Inc (Kezar Life Sciences) is a clinical-stage biotechnology company that discovers and develops small molecule therapies to treat autoimmunity and cancer. The company’s lead product candidate, KZR-616, an immunoproteasome inhibitor intended for the treatment of various au …
  • Ono Pharmaceutical Co Ltd (4528):医療機器:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Mesoblast Ltd (MSB):製薬・医療:M&Aディール及び事業提携情報
    Summary Mesoblast Ltd (Mesoblast) is a regenerative medicine company, which develops regenerative cell-based products. Its pipeline product candidates include MPC-150-IM, which is under development for the treatment of chronic congestive heart failure; MSC-100-IV, for the treatment of acute graft ve …
  • Oncolytics Biotech Inc (ONC):医療機器:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • Beverages & More Inc:企業の戦略的SWOT分析
    Beverages & More Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • VytronUS Inc:医療機器:M&Aディール及び事業提携情報
    Summary VytronUS Inc (VytronUS), formerly CardionUS Inc, is an independent clinical stage medical device company that develops technologies for the treatment atrial fibrillation and other cardiac arrhythmias. The company is developing a catheter-based imaging and ablation platform based on low-inten …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • P.F. Chang’s China Bistro, Inc.:企業の戦略・SWOT・財務情報
    P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Viztek LLC-医療機器分野:企業M&A・提携分析
    Summary Viztek LLC (Viztek), a subsidiary of Konica Minolta Medical Imaging USA Inc is a healthcare technology company that offers digital software and hardware imaging solutions. The company offers products such as opal-ORTHO, Opal-wRIS, CR, opal-CR II, opal-CHIRO, opal-RAD, opal-CLOUD, Viztek DR, …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Republic Bancorp, Inc.:企業の戦略・SWOT・財務情報
    Republic Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hewlett Packard Enterprise Company (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Company (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Societa Reale Mutua Di Assicurazioni:企業の戦略・SWOT・財務情報
    Societa Reale Mutua Di Assicurazioni - Strategy, SWOT and Corporate Finance Report Summary Societa Reale Mutua Di Assicurazioni - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Larsen & Toubro Ltd (LT):企業の財務・戦略的SWOT分析
    Larsen & Toubro Ltd (LT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mapfre SA (MAP):企業の財務・戦略的SWOT分析
    Mapfre SA (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Biomm SA (BIOM3):製薬・医療:M&Aディール及び事業提携情報
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆